Driehaus Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.2M | Sell |
1,269,952
-188,070
| -13% | -$11.9M | 0.64% | 39 |
|
|
2025
Q1 | $77.2M | Buy |
1,458,022
+167,047
| +13% | +$8.85M | 0.74% | 32 |
|
|
2024
Q4 | $72.3M | Sell |
1,290,975
-8,515
| -0.7% | -$477K | 0.6% | 38 |
|
|
2024
Q3 | $68.1M | Buy |
1,299,490
+117,120
| +10% | +$6.14M | 0.58% | 46 |
|
|
2024
Q2 | $48.5M | Buy |
1,182,370
+326,865
| +38% | +$13.4M | 0.47% | 66 |
|
|
2024
Q1 | $37.1M | Buy |
855,505
+256,600
| +43% | +$11.1M | 0.37% | 78 |
|
|
2023
Q4 | $27.5M | Buy |
598,905
+324,381
| +118% | +$14.9M | 0.33% | 97 |
|
|
2023
Q3 | $6.29M | Buy |
274,524
+251,531
| +1,094% | +$5.77M | 0.08% | 267 |
|
|
2023
Q2 | $379K | Hold |
22,993
| – | – | ﹤0.01% | 351 |
|
|
2023
Q1 | $410K | Hold |
22,993
| – | – | 0.01% | 343 |
|
|
2022
Q4 | $670K | Hold |
22,993
| – | – | 0.01% | 308 |
|
|
2022
Q3 | $563K | Buy |
+22,993
| New | +$563K | 0.01% | 313 |
|